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An epidemiological, strategic and response
analysis of the COVID-19 pandemic in South
Asia: a population-based observational study
Hafiz Muhammad Salman1, Javaria Syed2, Atif Riaz3, Zouina Sarfraz4, Azza Sarfraz5*,
Syed Hashim Abbas Ali Bokhari5 and Ivan Cherrez Ojeda6

Abstract
Introduction: South Asia has had a dynamic response to the ongoing COVID-19 pandemic. The overall burden and
response have remained comparable across highly-burdened countries within the South Asian Region.
Methodology: Using a population-based observational design, all eight South Asian countries were analyzed using
a step-wise approach. Data were obtained from government websites and publicly-available repositories for population dynamics and key variables.
Results: South Asian countries have a younger average age of their population. Inequitable distribution of resources
centered in urban metropolitan cities within South Asia is present. Certain densely populated regions in these countries have better testing and healthcare facilities that correlate with lower COVID-19 incidence per million populations.
Trends of urban-rural disparities are unclear given the lack of clear reporting of the gaps within these regions. COVID19 vaccination lag has become apparent in South Asian countries, with the expected time to complete the campaign
being unfeasible as the COVID-19 pandemic progresses.
Conclusion: With a redesigning of governance policies on preventing the rise of COVID-19 promptly, the relief on
the healthcare system and healthcare workers will allow for adequate time to roll out vaccination campaigns with
equitable distribution. Capacity expansion of public health within the Region is required to ensure a robust healthcare
response to the ongoing pandemic and future infectious disease outbreaks.
Keywords: South Asia, Urban, Rural, Age, Testing, Vaccine, Case-fatality Ratio, COVID-19
Introduction
Eight countries constitute South Asia, including Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka, forming the South Asian Association
for Regional Cooperation (SAARC). As of May 10, 2021,
this region is responsible for 25.26 million (15.83%)
COVID-19 cases and 0.29 million (8.69%) COVID-19
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deaths globally [1]. The South Asian Region is home to
23.75% of the global population, and the transmission of
COVID-19 in this Region has remained dynamic [2]. Initial projections predicted a higher burden of COVID-19
cases and deaths given the lack of adequate healthcare
infrastructure in South Asia [3, 4]. Additionally, highly
dense populations within urban settings and overall socioeconomic vulnerabilities across South Asia led to great
concern from public health bodies across the globe [5].
Within high-income countries (HICs), many patients
admitted to the hospitals and at higher risk of mortality were minority ethnic groups, including South Asians
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[6]. Various underlying factors that were cited included
a higher risk of chronic diseases, especially diabetes and
cancer, which increases the relative risk of the hazard
ratio for mortality due to COVID-19 [7–9]. The triad of
compromised public health infrastructure, under-trained
human resources, and contributory environmental factors has been cited as a vector for further viral transmission in the South Asian Region [10, 11].
South Asian countries share similar socioeconomic
backgrounds with fragile health systems. South Asia has
previously had gaps in public health preparedness and
response to infectious disease outbreaks, notably during the Cholera outbreak. The COVID-19 pandemic
has highlighted a lack of a robust infectious control system within this region [12]. The Region’s public health is
already challenged with a high rate of preventable morbidity and mortality, which requires exploration to aid
in the effective management and control of infectious
disease outbreaks [11]. In this study, we explored the vulnerabilities in the healthcare system across South Asian
countries during the COVID-19 pandemic. We focused
on the epidemiology, preparedness, and strategies contributing to the dynamic spread of COVID-19 in this
Region. We expanded on specific countries that have had
a higher burden of COVID-19 in the Region. Specific factors that we explored included age-distribution patterns,
the capacity of COVID-19 testing, vaccination efforts,
and prospects across the Region.

Methodology
Data were monitored between March 1, 2020, to May 19,
2021, to understand the transmission patterns among
people within SAARC. A population-based observational survey was conducted by obtaining data from government websites of SAARC (iedcr.gov.bd,covid.gov.pk,
corona.mygov.in, covid19.gov.lk, https://heoc.moph.gov.
np/update on-novel-coronavirus-covid-19/moh.gov.bt/
novel-coronavirus-2019-ncov/,
https://covid19.health.
gov.mv/d ashb o ard/af.u seembbasy. gov/ covid- 19-infor
mation/) , Statista, Worldometer, the European Center
for Disease Control and Prevention (CDC), John Hopkins
University of Medicine Coronavirus Resource Center,
and the World Health Organization (WHO) dashboard.
Population dynamics were obtained from country-specific latest Census Statistics and Statista when applicable. Other sources, including peer-reviewed articles on
the MEDLINE and Scopus database, were also reviewed
to obtain the latest updates on countries within SAARC.
Search terms were used with Boolean operators and
included “South Asia”, “pandemic”, “COVID-19”, “Coronavirus”, “response”, “preparedness”, “strategies”, and
“healthcare”. Only studies that reported healthcare preparedness and response to the COVID-19 pandemic were
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included. The current study was exempt from the Institutional Review Board (IRB) due to the secondary analysis
of publicly available data. The primary outcome was the
correlation of country-wise and regional age distribution,
testing facilities and population density, and vaccination
rollout efforts within South Asian countries. The secondary outcome was the exploration of gaps in the COVID19 pandemic to inform healthcare responses within the
public health domain. The analysis was conducted using
data from government websites with a detailed step-bystep guide attached (Fig. 1).

Results
Current Situation in SAARC

Three countries in the Region with the highest popultion have had the highest burden of reported COVID19 infections, namely India, Pakistan, and Bangladesh.
As of May 10, 2021, over 24.63 million cases have been
identified among these three countries, which is likely
to be underestimated. Screening methods have incorporated airport screening from international travelers with
no testing for intra-country travelers. Such screening is
beneficial yet does not capture all the patients’ incubation periods. Government-imposed social distancing
and lockdown measures have been helpful in the Region.
However, the testing capacity and facilities have been
sub-optimal. The three most impacted countries, India,
Pakistan, and Bangladesh, had continued to report high
cases in the post-lockdown period after June 2020.
Age‑distribution Patterns

The median age of the population in the Region ranges
from 22.8 to 34 years in 2020 (Fig. 2). Among SAARC
countries, COVID-19 was reported most frequently
among the age group below 50 years [13]. Attributed
factors include environmental and individual, such
as potential ignoring of social distancing protocols to
continue working and maintaining employment [10].
Higher incidence in the younger age groups is also
likely due to the effective following of social distancing
and social welfare programs among older age groups
[14]. The case-fatality ratio (CFR) among the SAARC
countries was 1.14%, lower than the global CFR of
2.08%. India has the highest burden of deaths within
the SAARC countries yet has a CFR of 1.09%, which
may be explained by a younger age distribution pattern.
Globally, the most vulnerable age group to contract
COVID-19 infection is within the age range of 18-64
years. However, the death rate was 45 times higher
among 30-39-year-olds and 8,700 times higher among
those aged 85 years and older [15]. Given the younger
population of the Region, it may be an underlying reason for the relatively lower CFR.
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Fig. 1 Step-wise breakdown of the employed methodology of epidemiological analysis

The Capacity of COVID‑19 Testing

The testing capacity of SAARC countries has received
attention, with Bangladesh being criticized for testing
a maximum of 15,000 tests for a population of 165 million [16]. All the SAARC countries with a high positivity
ratio expanded their testing centers in the past year. The
overall tests conducted in the countries with the heaviest burden of COVID-19 per 100 million people were the

highest in India. The number of testing facilities available
per 100 million people is demonstrated in Fig. 3. Interestingly, India has performed the highest number of tests
per million people compared to their testing capacity, followed by Bangladesh and Pakistan, as demonstrated in
Fig. 3. However, the overall burden of COVID-19 remains
the highest in India. Across all these countries, there has
been a gap of the testing centers in proportion to the
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Fig. 2 Median Age of SAARC Countries in 2020

population density. There is minimal infrastructure to
access rural and remotely-located districts, compounded
with social distancing protocols, with greater availability
of testing centers primarily in urban and semi-urban settings [17]. There has been a recent spike in the incidence
of COVID-19 across the SAARC countries, which has
been attributed to the downplaying of the nature of the
pandemic, lack of preventive measures taken among citizens, and delayed responses the governments to contain
the pandemic. Countries including Bhutan, Maldives,

Nepal, and Sri Lanka have performed much better than
their regional counterparts due to timely action and
effective measures such as social distancing [11].
Responses to COVID‑19

Following the confirmation of the first COVID-19 diagnosed case in each SAARC country, the number of critical days it took for the government to impose a lockdown
was variable, with Sri Lanka taking action before its
first confirmed case. All the South Asian countries had

Fig. 3 The number of testing centers per 100 million people and the testing rate per 1000 people in the SAARC countries with the highest
COVID-19 cases
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set a lockdown within one month of the first diagnosed
case except India, which implemented the lockdown on
March 25, 2020, approximately seven weeks after its first
confirmed COVID-19 case. However, South Asia took
formidable action quicker than the United States, United
Kingdom, and European countries. Despite nationwide
lockdowns being implemented between March 15 to 25,
2020, the number of COVID-19 cases have continued
to rise. The interventions in South Asia have focused
on implementing strict lockdown measures through
suppression. There has been a lack of COVID-19 containment among five countries, including Afghanistan,
Bangladesh, India, Nepal, and Pakistan. Overall, the CFR
in South Asia has been lower than that of the developed
countries. However, individual analysis of Pakistan and
India places both these countries in the top twenty countries, as per the CFR and deaths per 100,000 populations.
The majority of the heavily-burdened countries in
South Asia (India, Pakistan, and Bangladesh) reside in
rural areas. The healthcare system in South Asia follows a
decentralized system with healthcare provision available
through public and private hospitals in three countries
(India, Pakistan, and Bangladesh). Limitations of healthcare resources among different states or regions within
India, Pakistan, and Bangladesh have been cited as causative for inadequacy to limit community transmission. As
of May 10, 2021, India has set up 2,542 testing facilities
for its total population of nearly 1.38 billion people. The
number of testing centers in Pakistan is 139 for its entire
population of 224 million people. Bangladesh received

criticism for its inadequate testing facilities and has set
up 459 centers for its population of 166 million. There
is a significant gap in the capacity of testing centers to
serve more populated districts. The number of COVID19 testing facilities per population density falls short as
the most densely populated states have a relatively lower
number of testing centers and a higher burden of cases
per million populations (Table 1). In the South Asian
Region, there has been a shortage of hospital beds per
state division. For instance, the number of beds in Islamabad, Pakistan, shows the availability of beds to be 1 for
every 38 patients on average per 1 million people. Uttar
Pradesh in India and Dhaka in Bangladesh are more competitive due to a stronger healthcare system prior to the
COVID-19 pandemic.
Regardless, the data demonstrated in Table 1 does not
account for rural-urban divisions. The testing centers
in terms of the highest population and density in India,
Pakistan, and Bangladesh highlight a significant gap in
the state of Bihar and Kerala in India, and Islamabad and
Khyber Pakhtunkhwa divisions in Pakistan. The gap has
also been noted in Bangladesh’s Dhaka and Mymensingh
divisions [16]. There is a centrality of testing centers in
urban metropolitan regions with concentrated tertiary
healthcare provision. These countries have a higher discrepancy of in-hospital services and testing centers. In
India’s recent COVID-19 wave, the number of testing
centers and hospital bed facilities did not rise in proportion to the number of COVID-19 cases and medical staff
and other technical facilities [18]. The healthcare system

Table 1 Population density and COVID-19 resources among five districts of India, Pakistan, and Bangladesh. We selected five states
with the highest population density. aNot available for each district
Country

India

Pakistan

Bangladesh

Population density
per sq. Km.

Number of COVID-19
testing facilities

COVID-19 cases per 1
million people

Number
of hospital
beds

Bihar

1,102

65

5,682

30,857

West Bengal

1,029

128

10,878

113,535

Kerala

859

159

56,965

99,227

Uttar Pradesh

828

241

7,525

281,402

Haryana

573

60

25,248

36,141

Islamabad

889

22

98,200

2,571

Punjab

358

54

4,376

60,387

Khyber Pakhtunkhwa

238

19

7,084

24,329

Sindh

216

38

9,679

38,623

Baluchistan

19

6

3,584

7,797

Dhaka

1,751

454a

15,053

131,248a

Mymensingh

1,074

852

Rajshahi

1,007

1,754

Rangpur

960

1,153

Chattogram

831

3,339
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in these countries has been cited as under-equipped to
serve all the population in rural and remote settings, as
well as urban settings as the cases rise in the metropolitan areas.

Vaccination Efforts
Lagging rollout of vaccinations has been noted in the
Region as countries with higher burdens, including India,
Pakistan, and Bangladesh, relaxed physical restrictions,
and detection of new variants of COVID-19. In the early
phase of the COVID-19 pandemic in June 2020, the
World Health Organization (WHO), Coalition for Epidemic Preparedness Innovations (CEPI), and Gavi, the
Vaccine Alliance funded by the Gates Foundation, developed a global initiative to improve access to COVID-19
vaccines [19]. The initiative to distribute two billion vaccine doses throughout 2021 began in February. Further,
the pandemic response has been supplemented with aid
from the World Bank to aid in vaccination access and
rollout in the Region. Of all the South Asian countries,
both Maldives and Bhutan have successfully administered the highest vaccinations per percentage of the total
population. Maldives and Bhutan vaccinated 5.5% and
8.9% per week, respectively. However, the three countries
with the highest burden of COVID-19, namely India,
Pakistan, and Bangladesh, had administered an average
of 0.8%, 0.1%, and 0.4% per week of the total population.
At this rate, India, Pakistan, and Bangladesh require 2.4
years, 19.2 years, and 4.8 years respectively, to vaccinate
their entire population. Other South Asian countries,
including Afghanistan, Nepal, and Sri Lanka, also lag in
the access and rollout of the COVID-19 vaccines, with
respective countries requiring 19.2 years, 3.8 years, and
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6.4 years. The percentage of the total population having
received one COVID-19 dose is summarized in Fig. 4,
with the latest estimates until May 19, 2021.
With a substantial amount of vaccination supply provided by COVAX partners, two primary roadblocks
need to be addressed during the vaccination campaign
by South Asian countries that have lagged. There is an
immediate need to increase the vaccine supply and restrategize the setting for the distribution campaign. For
instance, the rural population constitutes 63-65% of the
three countries with the highest burden of COVID-19
[20]. However, these settings have a scarcity of public
health and primary care clinics [21]. This warrants an
equitable distribution through collaboration with primary care facilities and their communities. Alongside,
as the vaccination campaign is rolled out, it is pertinent
to control the high rate of COVID-19 transmission present in certain South Asian countries. Such containment
measures may be possible through transparent prompt
reporting of the data by the government, stopping mass
religious or political gatherings, tracking hotspots, and
necessitating masks and social distancing.

Discussion
There has been a notable difference in the testing strategies, laboratory strategies, and healthcare provision
among and within South Asian countries [11]. The insufficient facilities and the ensuing community transmission during the early stage of the pandemic have not been
met with adequate governance in the region due to premature and discontinuation of social distancing policies
[22]. So far, South Asia has been observed to have lower
CFRs which may be underestimated. The CFR of Pakistan

Fig. 4 Percentage of the total population vaccinated among SAARC countries until May 19, 2021
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is the highest in the region, yet Pakistan had the most
insufficient testing capacity in the Region, as noted in our
analysis. However, in the initial phase of the COVID-19
pandemic, Pakistan’s CFR was significantly lower, which
is suggestive of the inadequate surveillance system. With
a growing number of cases, the CFR has increased in
Pakistan, and it presents two possible dilemmas: 1) the
number of individuals being tested is more severely ill,
resulting in an overestimation of CFR, and 2) the number
of mild-to-moderate COVID-19 cases are under-represented due to under-testing of patients. A bias noted in
the trends of CFR in the Region may be present, yet there
is notable ongoing improvement in the testing capacity.
Following trajectories of lockdown and post-lockdown
trends in the SAARC countries, smaller countries were
able to control their COVID-19 transmission. However, the three most affected countries (India, Pakistan,
and Bangladesh) eased lockdowns without curbing the
transmission of COVID-19 cases. Before recommending nationwide lockdowns during the ongoing wave of
the COVID-19 pandemic, certain highly dense hotspots
need to be considered, such as Mumbai, Karachi, and
Dhaka, the three most populated urban cities in India,
Pakistan, and Bangladesh [11]. Selective hotspots require
localized lockdowns for 2-3 weeks with active surveillance and strict quarantine measures to prevent a severe
outbreak in these countries. A public health approach
necessitates curbing the peak (the exponential growth in
COVID-19 infection requiring medical supplies) a few
weeks before it occurs. Gaps in response preparedness in
the Region include shortages in hospital beds, ventilators,
quarantine facilities, and a lack of standardized treatment
protocols due to different variants, which present delays
in health provision [12]. SAARC countries have received
testing kits, ventilators, vaccinations, and aid from international regulatory bodies. However, the overall health
expenditure in the three most impacted and populated
countries (India, Pakistan, and Bangladesh) is less than
1% of GDP [23]. The total availability of hospital beds
is lower than 10 per 1000 populations in all the SAARC
countries except Bhutan [24]. Further, the World Bank
has predicted that SAARC countries will face their worst
economic crisis due to the ongoing COVID-19 pandemic.
Within the socioeconomic context of the South Asian
Region, the health systems have already witnessed a scarcity of healthcare resources. The COVID-19 pandemic
further aggravated the gaps in healthcare resources [17].
The pressure to ease lockdowns was also felt due to the
economic losses faced by these countries. In the South
Asian context, the lack of clarity within the urban-rural
disparity in testing, vaccination access and acceptance, and treatment presents a challenge. High-burden
countries (India, Pakistan, Bangladesh, Sri Lanka, and
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Afghanistan) in the Region have reported shortages in
medical supplies such as oxygen, hospital beds, and personal protective equipment (PPE) [25]. The detection
of emerging strains was compounded by a lack of mitigation strategies and the country’s catastrophic second
wave of COVID-19 [18]. With the Region, it is also pertinent to eliminate false reports [26]. Misinformation
concerning COVID-19 infection and vaccination needs
to be addressed through education, catering to eliminating vaccine hesitancy and promoting the application of
safety protocols (masks, distancing) [27].
A limitation of the available data from the government
sites is the potential underestimation of the actual scenario. For instance, data quality and confounders were
not elucidated at public repositories. Also, as the current study focuses on a population-level analysis, we were
unable to explore individual-level factors. Regardless, this
study focuses on estimating country-level representative
data that may be generalizable for public health bodies at
a national level.
Future Scope of the Work

The SARS-CoV-2 virus has been identified with a large
number of variants, and there is uncertainty regarding
its transmissibility, immune system evasion, and severity. The new variant B.1.1.529, named Omicron, was
detected on November 26, 2021, and it is being considered a variant of concern as cases are spiking globally
[28]. As of December 31, 2021, 6 countries in the South
Asian Region, including India, Pakistan, and Bangladesh, which have had the highest burdens in previous
waves, have reported confirmed Omicron cases. Within
the Region, countries have previously experienced a few
waves of the COVID-19 pandemic. All three previously
high-burdened countries, including India, Pakistan, and
Bangladesh, have 40%, 31%, and 32% of their population
primarily vaccinated. Booster doses of mRNA vaccines
are also being administered in the Region, with preliminary results suggesting a 20-40-fold reduction in neutralizing antibody activity for Omicron [29]. The severe
shortfall in vaccine supply across the region is likely to
predispose underprivileged communities within these
countries to the Omicron outbreak [30]. These gaps are
especially pronounced in rural settings as the majority of
the information-sharing mechanisms are available online
[31, 32]. Further, appropriate public health measures to
mitigate risk are needed including vaccination; however,
this may not be sufficient [33]. There is rising concern
that emerging strains may reduce the immunity of previously vaccinated individuals.
The recommended course with the rise of Omicron
is to accelerate vaccination of high-priority groups and
strengthen health systems. The COVID-19 pandemic
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has highlighted the vulnerabilities of the healthcare system in the Region. The lack of robust public health infrastructure and personnel was apparent, and there is an
urgent need to address the health systems disparities in
the Region [34]. Countries with higher COVID-19 cases
in the region have expanded their expenditure on capacity building in healthcare [35]. However, countries with
better healthcare structures, less poverty, and a younger
population in the Region have performed similarly to
their counterparts [35]. India has played a critical role in
setting the emergency fund for the public health expenditure of SAARC countries [36]. Even as SAARC addresses
challenges in its public health system, there is an urgent
need for a stronger healthcare investment to promote
health security. SAARC needs to act in unison through
pooled resources to improve vaccine coverage, access to
medicines, PPEs, and other equipment and services [37].
The public health infrastructure may focus on improving efficiencies by introducing online disease surveillance
systems, telemedicine, and point-of-care tests, which
are already in use in developed countries. Similarly,
effective mitigation strategies include strict quarantine
measures, equipped diagnostic facilities, and public education. As the region shares similar challenges in public
health, it is pertinent to consider a collated, cost-effective
plan to combat the ongoing COVID-19 pandemic and
future infectious disease outbreaks.

Conclusion
• The challenges to the COVID-19 outbreak in the
Region are similar due to weak healthcare systems and comparable socioeconomic backgrounds.
• The urban-rural disparities have not been documented in national datasets despite a significant ratio
of the population belonging to rural settings, with
services not reaching these remote and inaccessible
areas.
• Trends of COVID-19 burden in more populated
states/territories are associated with an overwhelmed
healthcare system, service provision gaps, and limited medical equipment and personnel primarily due
to economic and capacity challenges.
• Vaccination rollouts in the Region have been met
with difficulty due to vaccine shortages, inequitable
distribution globally, vaccine hesitancy, and the low
health capacities of the countries.
• Several actions taken in the previous waves of the
COVID-19 pandemic have promoted the capacity
building of public health in the Region; yet, the public
health capacity requires further expansion within and
across the Region’s countries.
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• Persistent gaps in healthcare provision must be
addressed to expand the provision of health services
with the ongoing Omicron variant and upcoming
infectious disease outbreaks.
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